Reviva Pharmaceuticals RVPH
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q1 | 0.95 | -4 | -6 | -56.98 | 7 | |
| 2024Q4 | 1.81 | 1 | -6 | -54.11 | 16 | |
| 2024Q3 | 1.44 | -10 | -8 | -106.69 | 8 | |
| 2024Q2 | 1.28 | -6 | -8 | -72.95 | 8 | |
| 2024Q1 | 3.78 | -1 | -7 | -39.97 | 13 | |
| 2023Q4 | 5.15 | 6 | -9 | -64.32 | 24 | |
| 2023Q3 | 4.88 | -9 | -11 | -127.42 | 5 | |
| 2023Q2 | 5.86 | 2 | -329.30 | -12 | -98.56 | 12 |
| 2023Q1 | 4.19 | 6 | -72.96 | -7 | -41.49 | 13 |
| 2022Q4 | 4.25 | 12 | -49.69 | -8 | -37.79 | 19 |
| 2022Q3 | 1.59 | 20 | -19.30 | -4 | -15.73 | 24 |
| 2022Q2 | 1.10 | 16 | -28.55 | -5 | -23.27 | 21 |
| 2022Q1 | 2.46 | 21 | -29.43 | -7 | -25.99 | 25 |
| 2021Q4 | 2.89 | 29 | -12.09 | -4 | -11.29 | 31 |
| 2021Q3 | 4.07 | 32 | -6.82 | -2 | -6.47 | 34 |
| 2021Q2 | 4.86 | 35 | -8.24 | -2 | -7.45 | 37 |
| 2021Q1 | 5.74 | 5 | -15.89 | -1 | -12.31 | 7 |
| 2020Q4 | 8.75 | 7 | -24.52 | -2 | -7.01 | 9 |
| 2020Q3 | 10.75 | 5 | -6.96 | 0 | -1.01 | 35 |
| 2020Q2 | 5 | -10.32 | -1 | -1.50 | 34 |